Pharmaceutical industry news from PDS

PDS news

9 August 2010
Pharmaceutical Development Services (PDS)
and Schiff and Company form alliance

An alliance has been announced which is bringing together leading experts in pharmaceutical regulation from both sides of the Atlantic. Schiff and Company Inc of West Caldwell, NJ, has joined forces with Pharmaceutical Development Services Ltd (PDS) of Nottingham, UK, to allow Schiff to offer PDS European regulatory expertise to its clients, while PDS will benefit from the worldwide contacts that Schiff will bring to the alliance.

PDS will be providing Regulatory and Quality Services to Schiff and Company clients in Europe while Schiff and Company will be targeting US based companies looking for local assistance in Europe. Such support would be provided in areas such as importation of Clinical Trials Materials, generation and submission of Clinical Trial Applications, Ethics Committee submissions, Investigator brochures etc. PDS also supplies a contract Qualified Person (QP) Release service for US-based clients, and can act as Local Agent for medicines and medical devices registered in Europe.

Dr Robert Schiff, CEO and President of Schiff and Company Inc, and Dr Michael Gamlen, Managing Director of Pharmaceutical Development Services (PDS), Nottingham UK, announced the alliance at a launch event at Schiff’s New Jersey offices and both saw great opportunities in working... Read more

Learn more about Schiff and Company
http://www.schiffandcompany.com

5 January 2010
Top pharmaceutical experts join the PDS front line team

Pharmaceutical Development Services Ltd (PDS) has announced major additions to its front line consultancy team with the appointment of Graham Clapperton to head up PDS quality services while John Hevizi brings extensive experience into PDS analytical and pharmaceutical development activities.

Graham Clapperton, BSc, FRSC, MCQI has been appointed Associate Director with responsibility for Quality and Compliance Services at the rapidly expanding consultancy. Graham has first rank experience in pharmaceutical quality management having spent 35 years at industry giant 3M, for the last twelve years as European
Quality Manager.

John Hevizi MSc, MRSC has enjoyed a career in pharmaceutical and analytical development at major companies including SmithKline Beecham and British BioTech Ltd where he held a range of senior positions including that of British BioTech’s Head of Pharmaceutical and Analytical... Read more

December 2009
Transatlantic Pharmaceutical Experts PDS expand team
to cover API Supplier Auditing

Pharmaceutical Development Services Ltd (PDS), the fast growing pharmaceutical consultancy with offices in the UK and South Carolina, is expanding its team of associates to meet growing demand and to provide the API (Active Pharmaceutical Ingredient) auditing capability demanded by companies keen to maintain their quality credentials with regulatory authorities.

New PDS Associates Paul Butler and Martin Slade have extensive CVs with particular expertise in API auditing in Europe, India and China making them a valuable resource to companies seeking low cost, high quality API suppliers.

PDS Managing Director Michael Gamlen says, “The nature of our business means we have to ensure we have the right people available to meet client needs. Having Martin and Paul available to add to the PDS body of expertise represents a considerable opportunity and I had no hesitation in bringing them onto the team. We are finding that API is a very hot topic at the moment. Some pharmaceutical sourcing, particularly from Asia, is proving of variable quality, leading to increased regulatory scrutiny. API Supplier Auditing is a key element of the international effort to maintain pharmaceutical supply chain integrity and avoid problems with counterfeit products and adulterated APIs. Expertise such as that possessed by Paul Butler and Martin Slade is not easy to come by, and having this capability as part of our package of services reassures clients that they will be able to respond to any regulatory challenges to their supply chain strategy. These appointments will consolidate PDS’ capability to offer comprehensive services to its growing number of US-based clients looking to benefit from services and product opportunities..." Read more

PDS news

keeping you up to date with important news